<p>The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.</p>
申请公布号
EP2566872(B1)
申请公布日期
2014.12.24
申请号
EP20110717099
申请日期
2011.04.14
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
WANG, TAO;YIN, ZHIWEI;ZHANG, ZHONGXING;PENDRI, ANNAPURNA;LI, GUO;GERRITZ, SAMUEL;ZHAI, WEIXU;SCOLA, PAUL MICHAEL;SUN, LI-QIANG;MULL, ERIC